Cleared Traditional

ZIEN IO Intraosseous Access System (K240915) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K240915 · Zien Medical Technologies, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2024
Decision
90d
Days
Class 2
Risk

K240915 is an FDA 510(k) clearance for the ZIEN IO Intraosseous Access System. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Zien Medical Technologies, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on July 2, 2024 after a review of 90 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Zien Medical Technologies, Inc. devices

Submission Details

510(k) Number K240915 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2024
Decision Date July 02, 2024
Days to Decision 90 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 129d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 196
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K240915.
Safety Winged Blood Collection Sets
K243806 · Promisemed Hangzhou Meditech Co., Ltd. · Jan 2025
ACE Cannula
K242741 · Ace Medical Industry Co., Ltd. · Jan 2025
Verifine® Pen Needles
K242632 · Promisemed Hangzhou Meditech Co., Ltd. · Sep 2024
Sterile Safety Hypodermic Needles for Single Use
K232165 · Berpu Medical Technology Co., Ltd. · Feb 2024
Sterile Hypodermic Needles for Single Use
K233037 · Zhejiang Kindly Medical Device Co., Ltd. · Dec 2023
SteriCap Safety Needle
K233343 · Ocuject, LLC · Nov 2023